Website
VCID: 351306
Profile
Corporate information
Official name
arGEN-X BV
Registration country
Official name
arGEN-X BV
Registration country
Investment activity status
Active investor
Company type
Innovation-driven biopharmaceutical company.Funding
Funding rounds
(1 Dec 2011)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Seventure Partners SA | Venture capital firm with a focus on hight growth European companies in the areas of information and communications technologies and life sciences | France |
(1 Feb 2010)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Life Sciences Partners BV | Specialized healthcare and biotechnology investment firm | Netherlands | Initial investment. Round participant. |
(1 Sep 2009)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Forbion Capital Partners Management Services BV | Netherlands |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
BioGeneration Ventures BV |
+31 (35) 699-3000 |
Series A |
|
|
Crédit Agricole Private Equity |
Series A | |
|
|
Forbion Capital Partners Management Services BV |
+31 (35) 699-3000 |
Series A |
|
|
KBC Private Equity NV |
+32 (2) 429-3645 |
Series A |
|
|
Life Sciences Partners BV Specialized healthcare and biotechnology investment firm |
+31 (20) 664-5500 |
Series A |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
N/A |
|
|
Seventure Partners SA Venture capital firm with a focus on hight growth European companies in the areas of information and communications technologies and life sciences |
+33 (1) 5819-2270 |
Series B |